Interferon-ribavirin-associated ischemic colitis

Journal of Clinical Gastroenterology

Volumn 42, Issue 3, 2008, Pages 323-325

  Punnam, Sujeeth R ^a,c   Pothula, Vijayasimha R ^a   Gourineni, Nandu ^a   Punnam, Aparna ^b   Ranganathan, Venkateshan ^b  

^a MICHIGAN STATE UNIVERSITY   (United States)

^b Nacogdoches Heart Clinic   (United States)

^c MICHIGAN STATE UNIVERSITY   (United States)

Author keywords

Adverse effects; Interferon ; Ischemic colitis; Ribavirin

Indexed keywords

PEGINTERFERON; RIBAVIRIN;

ABDOMINAL CRAMP; ADULT; ARTICLE; BLEEDING; CANCER SCREENING; CASE REPORT; COLONOSCOPY; COMPUTER ASSISTED TOMOGRAPHY; DRUG WITHDRAWAL; ERYTHROCYTE COUNT; FAMILY HISTORY; FECES ANALYSIS; HEPATITIS C; HUMAN; HYPERTENSION; ISCHEMIC COLITIS; LABORATORY TEST; LEUKOCYTE COUNT; MALE; MEDICAL LITERATURE; MICROSCOPY; PHYSICAL EXAMINATION; PRIORITY JOURNAL; SMOKING; THROMBOCYTE COUNT; VASCULAR DISEASE;

ANTIVIRAL AGENTS; BIOPSY; COLITIS, ISCHEMIC; COLON; COLONOSCOPY; DRUG THERAPY, COMBINATION; FOLLOW-UP STUDIES; HEPATITIS C, CHRONIC; HUMANS; INTERFERON-ALPHA; MALE; MIDDLE AGED; RIBAVIRIN;

EID: 39749093783     PISSN: 01920790     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.mcg.0000225637.37533.68     Document Type: Article

References (10)

1. Alter MJ. The epidemiology of acute and chronic hepatitis C. Clin Liver Dis. 1997;1:559.
2. Alter MJ, Margolis HS, Krawczynski K, et al. The natural history of community-acquired hepatitis C in the United States. The Sentinel Counties Chronic non-A, non-B Hepatitis Study Team. N Engl J Med. 1992;327:1899.
3. Third National Health and Nutrition Examination Survey (NHANES III). National Center for Health Statistics (CD-ROM Catalog No. PB97-502959), United States 1995. Hyattsville, MD: Public Health Service; 1996.
4. Aijaz Ahmed, Keeffe EB. Hepatitis C Virus Infection. Textbook of Gastroenterology. 4th ed. Chapter 108. Philadelphia: Lippincott Williams and Wilkins; 2003:2339.
5. Chang CH, Chen KY, Lai MY, et al. Meta-analysis: ribavirin-induced haemolytic anaemia in patients with chronic hepatitis C. Aliment Pharmacol Ther. 2002;16:1623-1632.
6. Okanoue T, Sakamoto S, Itoh Y, et al. Side effects of high dose interferon therapy for chronic hepatitis C. J Hepatol. 1996;25:283-291.
7. Tada H, Saitoh S, Nakagawa Y, et al. Ischaemic colitis during interferon-alpha treatment for chronic active hepatitis C. J Gastroenterol. 1996;31:582-584.
8. Sparano JA, Dutcher JP, Kaleya R, et al. Colonic ischemia complicating immunotherapy with interleukin-2 and interferon alpha. Cancer. 1991;68:1538-1544.
9. Brandt LJ, Smithline AE. Ischemic lesions of the bowl. In: Feldman M, Scharschmidt BF, Sleisenger MH, eds. Sleisenger & Fordtran's Gastrointestinal and Liver Disease. 6th ed. Philadelphia: WB Saunders; 1998:2009-2024.
10. Panes J, Pique JM. Ischemic Colitis. Textbook of Gastroenterology. 4th ed. Chapter 131. Philadelphia: Lippincott Williams and Wilkins; 2003:2755.